Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shuling Jianpi Capsule in diarrhea-predominant irritable bowel syndrome (phase IV, single-arm)
CTR20171305Phase 4Completed
- Sponsor
- Jinling Pharmaceutical
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Shuling Jianpi in Diarrhea-predominant irritable bowel syndrome (IBS-D), sponsored by Jinling Pharmaceutical. Started Jan 2018; status: completed.
02
Drugs
Shuling Jianpi
03
Conditions
Diarrhea-predominant irritable bowel syndrome (IBS-D)
Beyond the preview
Go deeper on CTR20171305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171305.